- Allergan (NYSE:AGN) has had no discussions with Valeant (VRX) or Bill Ackman's Pershing Square about a possible takeover of the Botox maker, nor has it received an offer.
- Allergan's board would evaluate any offer that was made, the company said. It was responding to filings by Valeant and Peshing Square about a potential deal. (PR)